Weekly Injection

    Mounjaro (Tirzepatide)

    The first and only dual GIP and GLP-1 receptor agonist, taken as a once-weekly injection.

    From £215/month

    Assessed and prescribed remotely where appropriate, with medication delivered to your home.

    Medically reviewed by Dr Chris Herman, GMC 2376587
    Last reviewed 5 September 2026

    What Is Mounjaro?

    Mounjaro (tirzepatide) is the first and only GIP and GLP-1 receptor agonist, providing dual-action weight management alongside dietary and lifestyle changes.

    As with all GLP-1 treatments, dosing starts low and is escalated gradually under clinical review.

    Available strengths: 2.5mg–15.0mg. Your clinician will determine the appropriate starting dose and escalation schedule for you.

    How It Works

    • Acts on two gut hormone pathways (GIP and GLP-1)
    • Reduces appetite and increases feelings of fullness
    • Slows gastric emptying

    Who May Be Suitable

    Treatment may be considered for adults who:

    • Have a BMI within a clinically defined range
    • Have weight-related health conditions (such as hypertension or type 2 diabetes), or
    • Meet other medical criteria set out in UK guidance

    A full medical history is required before any prescribing decision is made. We do not prescribe for cosmetic weight loss.

    How It's Administered

    • Self-injected once a week, on the same day each week, using a pre-filled pen
    • Injected under the skin (subcutaneously) into the abdomen, thigh, or upper arm
    • Injection sites should be rotated each week to reduce irritation
    • Your clinician or a member of our team will talk you through injection technique before you start
    • Can be taken with or without food, at any time of day

    Who Should Not Use This Treatment

    Treatment is unlikely to be suitable if you:

    • Are pregnant, breastfeeding, or trying to conceive
    • Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
    • Have a known hypersensitivity to tirzepatide or any other ingredient in Mounjaro
    • Have type 1 diabetes
    • Have a history of pancreatitis or severe gastrointestinal disease (this will be reviewed individually)

    This is not a complete list. Your clinician will review your full history during assessment.

    Common Side Effects

    • Nausea, vomiting, or diarrhoea
    • Constipation or indigestion
    • Abdominal pain or bloating
    • Reduced appetite
    • Fatigue or headache
    • Injection site reactions

    Serious Warning Signs

    Seek urgent medical attention if you experience:

    • Severe, persistent abdominal pain (possibly spreading to your back), with or without vomiting — may indicate pancreatitis
    • Pain in the upper right abdomen, fever, or yellowing of the skin or eyes — may indicate a gallbladder problem
    • Swelling of the face, lips, tongue, or throat, or difficulty breathing — signs of a severe allergic reaction
    • A lump or swelling in the neck, hoarseness, or difficulty swallowing — should be reported promptly
    • Symptoms of very low blood sugar if you also take other diabetes medication (shakiness, sweating, confusion)
    • Signs of dehydration or kidney problems following prolonged vomiting or diarrhoea

    Monitoring We Provide

    • An initial clinical assessment covering your medical history, weight, BMI, and relevant health conditions
    • Scheduled clinical reviews before each dose increase to check tolerability and progress
    • Ongoing access to message our clinical team between appointments
    • Periodic review of your weight, side effects, and overall suitability to continue treatment

    If You Want To Stop

    • You can stop treatment at any time — there is no obligation to continue
    • We recommend telling your prescribing clinician so they can advise on stopping safely
    • Clinical trial evidence shows weight regain is common after stopping GLP-1 treatment, so your clinician can discuss a plan for maintaining results
    • Your subscription can be paused or cancelled in line with our cancellation policy

    Cost, Prescription & Delivery

    • From £215/month, including your prescription, medication, and ongoing clinical support
    • Medication is dispensed by a UK-regulated pharmacy and delivered in discreet, temperature-controlled packaging
    • Pricing may vary by dose as your treatment is titrated — your clinician will confirm costs at each stage
    • No long-term contract — you can pause or cancel your subscription at any time

    Frequently Asked Questions

    About Mounjaro

    Dosage & Administration

    Impact & Side Effects

    Common side effects of GLP-1 medicines may include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and reduced appetite. Treatment outcomes vary between individuals and weight loss is not guaranteed. Mounjaro is prescription-only and offered following clinical assessment.

    Ready to find out if Mounjaro is right for you?

    Complete our online suitability check and our GP-led clinical team will personally review your information.